Essex Bio-Technology (HK:1061) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Essex Bio-Technology Limited reported a decrease in turnover and profit for the first half of 2024 compared to the same period in 2023, with turnover down by 9.8% and profit by 7.3%. Despite the downturn, the company’s total assets and net assets increased by 4.9% and 4.8% respectively, and it raised its interim dividend from HK4.5 cents to HK6.0 cents per ordinary share. Financial ratios such as gross profit margin and net profit margin showed slight variations, indicating changes in profitability and efficiency.
For further insights into HK:1061 stock, check out TipRanks’ Stock Analysis page.